{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:02:00Z","timestamp":1759881720287,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008353","name":"Funda\u00e7\u00e3o de Apoio ao Ensino, Pesquisa e Assist\u00eancia do Hospital das Cl\u00ednicas da Faculdade de Medicina de Ribeir\u00e3o Preto da Universidade de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2010-51729-2"],"award-info":[{"award-number":["2010-51729-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.abd.2022.11.005","type":"journal-article","created":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T09:10:00Z","timestamp":1687425000000},"page":"774-780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dexamethasone-cyclophosphamide pulse therapy outcomes comparing pemphigus vulgaris and pemphigus foliaceus groups in a Brazilian cohort study"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4885-8340","authenticated-orcid":false,"given":"Ludmilla Figueiredo","family":"Fontenelle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2871-0306","authenticated-orcid":false,"given":"Roberto","family":"Bueno-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8589-0089","authenticated-orcid":false,"given":"Sebasti\u00e1n","family":"Vernal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2143-9050","authenticated-orcid":false,"given":"Renata","family":"Delfino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3387-1219","authenticated-orcid":false,"given":"Giovanna Stefanne L\u00f3pes","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9457-9601","authenticated-orcid":false,"given":"Eduardo Antonio","family":"Donadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2709-1825","authenticated-orcid":false,"given":"Ana Maria","family":"Roselino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2022.11.005_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.808536","article-title":"Autoimmune pemphigus: latest advances and emerging therapies","volume":"8","author":"Lim","year":"2022","journal-title":"Front Mol Biosci."},{"key":"10.1016\/j.abd.2022.11.005_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.605214","article-title":"Common denominators in the immunobiology of IgG4 autoimmune diseases: what do glomerulonephritis, pemphigus vulgaris, myasthenia gravis, thrombotic thrombocytopenic purpura and autoimmune encephalitis have in common?","volume":"11","author":"Koneczny","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.abd.2022.11.005_bib0015","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.4269\/ajtmh.17-0100","article-title":"Spatial distribution of pemphigus occurrence over five decades in Southeastern Brazil","volume":"97","author":"Celere","year":"2017","journal-title":"Am J Trop Med Hyg."},{"key":"10.1016\/j.abd.2022.11.005_bib0020","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/exd.13342","article-title":"Herpes simplex virus 1 and cytomegalovirus are associated with pemphigus vulgaris but not with pemphigus foliaceus disease","volume":"26","author":"Machado","year":"2017","journal-title":"Exp Dermatol."},{"key":"10.1016\/j.abd.2022.11.005_bib0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtemb.2018.09.005","article-title":"Trace element profile in pemphigus foliaceus and in pemphigus vulgaris patients from Southeastern Brazil","volume":"51","author":"La Serra","year":"2019","journal-title":"J Trace Elem Med Biol."},{"key":"10.1016\/j.abd.2022.11.005_bib0030","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/bjd.19221","article-title":"Pemphigus foliaceus and sand fly bites: assessing the humoral immune response to the salivary proteins maxadilan and LJM11","volume":"183","author":"Vernal","year":"2020","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2022.11.005_bib0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaut.2016.04.007","article-title":"Differential HLA class I and class II associations in pemphigus foliaceus and pemphigus vulgaris patients from a prevalent Southeastern Brazilian region","volume":"72","author":"Brochado","year":"2016","journal-title":"J Autoimmun."},{"key":"10.1016\/j.abd.2022.11.005_bib0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1590\/abd1806-4841.2019940206","article-title":"Consensus on the treatment of autoimmune bullous dermatoses: pemphigus vulgaris and pemphigus foliaceus - Brazilian Society of Dermatology","volume":"94","author":"Porro","year":"2019","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2022.11.005_bib0045","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1590\/abd1806-4841.20142930","article-title":"Prevalence of Metabolic Syndrome and its components in a Brazilian sample of pemphigus patients","volume":"89","author":"Ambiel","year":"2014","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2022.11.005_bib0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00403-022-02346-y","article-title":"Association of autoimmune blistering disease, and specifically, pemphigus vulgaris, with cardiovascular disease and its risk factors: a systematic review and meta-analysis","volume":"315","author":"Rokni","year":"2023","journal-title":"Arch Dermatol Res."},{"key":"10.1016\/j.abd.2022.11.005_bib0055","first-page":"269","article-title":"Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus","volume":"137","author":"Borradori","year":"2001","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.abd.2022.11.005_bib0060","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1590\/abd1806-4841.20143128","article-title":"Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil","volume":"89","author":"Biot Sdel","year":"2014","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2022.11.005_bib0065","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1590\/abd1806-4841.20131905","article-title":"Off-label use of rituximab in dermatology: pemphigus treatment","volume":"88","author":"Bomm","year":"2013","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2022.11.005_bib0070","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1590\/abd1806-4841.20131990","article-title":"Severe multi-resistant pemphigus vulgaris: prolonged remission with a single cycle of rituximab","volume":"88","author":"Corral","year":"2013","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2022.11.005_bib0075","first-page":"179","article-title":"Cyclophosphamide pulses in the treatment of rheumatic diseases: an update","volume":"9","author":"De Vita","year":"1991","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.abd.2022.11.005_bib0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2133.1988.tb07104.x","article-title":"Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigus","volume":"119","author":"Pasricha","year":"1988","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2022.11.005_bib0085","first-page":"323","article-title":"Pulse therapy as a cure for autoimmune diseases","volume":"69","author":"Pasricha","year":"2003","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"10.1016\/j.abd.2022.11.005_bib0090","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1365-4362.1995.tb04430.x","article-title":"Dexamethasone-cyclophosphamide pulse therapy for pemphigus","volume":"34","author":"Pasricha","year":"1995","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.abd.2022.11.005_bib0095","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaad.2020.08.028","article-title":"Network meta-analysis-based comparison of first-line steroid-sparing adjuvants in the treatment of pemphigus vulgaris and pemphigus foliaceus","volume":"85","author":"Lee","year":"2021","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2022.11.005_bib0100","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0733-8635(05)70194-7","article-title":"Pulse intravenous cyclophosphamide therapy for dermatologic disorders","volume":"18","author":"Fox","year":"2000","journal-title":"Dermatol Clin."},{"key":"10.1016\/j.abd.2022.11.005_bib0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/idoj.idoj_397_21","article-title":"The demographic attributes, clinical features, and optimal management of 143 patients with pemphigus: a retrospective observational study from a tertiary care center of India","volume":"13","author":"Mahajan","year":"2022","journal-title":"Indian Dermatol Online J."},{"key":"10.1016\/j.abd.2022.11.005_bib0110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4103\/ijdvl.IJDVL_175_17","article-title":"A review of pulse therapy in 74 patients with pemphigus","volume":"84","author":"Roga","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"10.1016\/j.abd.2022.11.005_bib0115","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1590\/abd1806-4841.20131840","article-title":"Pulse therapy in pemphigus: report of 11 cases","volume":"88","author":"Fernandes","year":"2013","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2022.11.005_bib0120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4103\/idoj.IDOJ_74_18","article-title":"Factors affecting the duration of phase 1 of dexamethasone-immunosuppressant pulse therapy for pemphigus group of disorders: a 10-year retrospective study in a tertiary care center","volume":"9","author":"Mundakkat","year":"2018","journal-title":"Indian Dermatol Online J."},{"key":"10.1016\/j.abd.2022.11.005_bib0125","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7241\/ourd.20134.150","article-title":"Pemphigus: a disease stamped in the skin","volume":"4","author":"Matias","year":"2013","journal-title":"Our Dermatol Online."},{"key":"10.1016\/j.abd.2022.11.005_bib0130","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4103\/jfmpc.jfmpc_114_19","article-title":"Pulse therapy: opening new vistas in treatment of pemphigus","volume":"8","author":"Mustafi","year":"2019","journal-title":"J Family Med Prim Care."},{"key":"10.1016\/j.abd.2022.11.005_bib0135","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/art.25061","article-title":"Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review","volume":"62","author":"Monach","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.abd.2022.11.005_bib0140","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4103\/0378-6323.136831","article-title":"Factors affecting the duration of phase I of dexamethasone - cyclophosphamide pulse therapy","volume":"80","author":"Nayak","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"10.1016\/j.abd.2022.11.005_bib0145","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4103\/0378-6323.82396","article-title":"Pemphigus in India","volume":"77","author":"Kanwar","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"10.1016\/j.abd.2022.11.005_bib0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4103\/ijd.IJD_306_20","article-title":"A comparative study to evaluate the efficacy and cost of rituximab versus dexamethasone cyclophosphamide pulse in patients of pemphigus vulgaris","volume":"66","author":"Das","year":"2021","journal-title":"Indian J Dermatol."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059623001356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059623001356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:42:50Z","timestamp":1759794170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059623001356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0365059623001356"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2022.11.005","relation":{},"ISSN":["0365-0596"],"issn-type":[{"type":"print","value":"0365-0596"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dexamethasone-cyclophosphamide pulse therapy outcomes comparing pemphigus vulgaris and pemphigus foliaceus groups in a Brazilian cohort study","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2022.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}